Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended Thromboprophylaxis with Redesca in Liver Resection
NCT06153394Phase 3Not yet recruiting
- Sponsor
- Western University
- Start
- Jun 2024
- Primary completion
- Feb 2025
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in thrombosis and Hypercoagulability (2 arms), sponsored by Western University. Primary endpoint: Number of participants with hypercoagulability identified via TEG testing at Day 90. Planned start Jun 2024; status: not yet recruiting.
02
Conditions
thrombosisHypercoagulability
Beyond the preview
Go deeper on NCT06153394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06153394.